Assembly Biosciences Inc
Assembly Biosciences Inc (ASMB) Implied Volatility Current
ASMB implied volatility is 76%. IV Rank is 16%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking ASMB implied volatility helps you identify when options premiums on Assembly Biosciences Inc are historically cheap or expensive, and where the best trades are hiding. Assembly Biosciences Inc implied volatility reflects the market's expectation of future price movement: when ASMB IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Assembly Biosciences Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ASMB, tracking metrics like ASMB IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ASMB signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc.
to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ASMB implied volatility sits today versus where it has been. Our scanner ranks Assembly Biosciences Inc implied volatility against its historical range, surfaces extremes in ASMB IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Assembly Biosciences Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track ASMB IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→